Mauro David J 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Feb 13, 2024
Insider Transaction Report
Form 4
Mauro David J
Chief Medical Officer
Transactions
- Award
Stock Option (RIght to Buy)
2024-02-09+99,537→ 99,537 totalExercise: $10.09Exp: 2034-02-09→ Class A Common Stock (99,537 underlying) - Award
Class A Common Stock
2024-02-09+6,040→ 196,753 total - Award
Class A Common Stock
2024-02-09+49,768→ 246,521 total - Tax Payment
Class A Common Stock
2024-02-09$10.09/sh−1,892$19,090→ 244,629 total
Holdings
- 381,426
Stock Option (Right to Buy)
Exercise: $8.77Exp: 2033-06-01→ Class A Common Stock (381,426 underlying)
Footnotes (5)
- [F1]This RSU vested immediately upon the grant date.
- [F2]This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2024 and every three months thereafter.
- [F3]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
- [F4]This option vests as to one fourth (1/4th) of the shares subject to the option on June 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter subject to Reporting Person's continued service to the Issuer through each such vesting date.
- [F5]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.